Premium
Discovery, characterization, and optimization of highly selective D 2 dopaminergic antagonists
Author(s) -
Free R. Benjamin,
Xiao Jingbo,
Doyle Trevor,
Conroy Jennie,
Titus Steve,
BryantGenevier Melanie,
Southall Noel,
Hu Xin,
Ferrer Marc,
Javitch Jonathan A,
Marugan Juan J,
Sibley David R
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.655.7
Subject(s) - adme , drug discovery , g protein coupled receptor , lead compound , chemistry , chemical space , docking (animal) , computational biology , receptor , small molecule , in vivo , dopaminergic , pharmacology , combinatorial chemistry , dopamine , biology , in vitro , medicine , biochemistry , neuroscience , genetics , nursing
The D 2 dopamine receptor (DAR) is central in the etiology and/or therapy of many neuropsychiatric disorders. Unfortunately, truly specific drugs for this receptor have been difficult to obtain, primarily due to high conservation of the orthosteric binding site within DAR subtypes and other G protein‐coupled receptors (GPCRs). In order to develop novel molecular scaffolds for the D 2 DAR, we used high throughput screening to interrogate a small molecule library and identify hit ligands with distinct functional characteristics, mechanisms of action, and selectivity among DAR subtypes. Here we present the discovery of a novel series of small molecule selective D 2 DAR antagonists found in this campaign. One such hit was optimized via medicinal chemistry efforts, and a lead compound was identified with high D 2 selectivity versus D 1 , D 3 , D 4 and D 5 DARs. Interestingly the binding of this compound to the D 2 DAR demonstrated near complete dependence on Na + . Furthermore, the lead compound showed favorable ADME and in vivo pharmacokinetic (PK) properties. In a profiling screen of a large panel of GPCRs the compound showed relatively low cross reactivity. This probe could be a useful pharmacological tool for studying structure activity relationships with the help of computational docking and simulations, as well as an ideal scaffold for the further development of even more highly selective D 2 DAR compounds.